Hayden is an assistant editor for The American Journal of Managed Care® (AJMC®) and joined AJMC® in 2021, where she produces written and video content covering multiple disease states.
She has a BA in journalism & media studies from Rutgers University. You can connect with Hayden on LinkedIn.
Higher Risk of Liver Disease Progression Seen Among Patients With PNPLA3 I148M Variant
October 7th 2022Individuals who were homozygous carriers of the PNPLA3 I148M genetic variant and reported excessive drinking and obesity had a 17.5 to 30.1 higher risk of progression to liver disease complications.
Read More
Improved QOL, Disease Activity Seen in Patients With IA Using Tailored Self-management App
September 24th 2022A mobile app providing self-management action advice to patients with inflammatory arthritis (IA) was linked to significant improvements in health-related quality of life (QOL) and disease activity.
Read More
Dr Hatim Husain Discusses HER2, Novel Therapy Exploration in Lung Cancer
September 23rd 2022During the Quality Cancer Care Alliance Summer 2022 National Leadership Summit, Hatim Husain, MD, discusses how HER2 exploration in lung cancer differs from that in breast cancer, as well as novel therapies being explored for HER2 and other disease targets.
Read More
Dr David Koren Discusses Barriers to Implementing Long-Acting Injectables for HIV
September 22nd 2022David E. Koren, PharmD, MPH, BCPS, AAHIVP, FIDSA, infectious disease clinical pharmacist at Temple University Hospital, explains the barriers both patients and providers face in implementing long-acting injectables for HIV.
Read More
Dr Pichamol Jirapinyo Discusses Endoscopic Gastric Plication in Patients With NAFLD
September 22nd 2022Pichamol Jirapinyo, MD, MPH, director of bariatric endoscopy fellowship at Brigham and Women's Hospital, explains the implications of her study on the effects of endoscopic gastric plication on liver fibrosis in patients with nonalcoholic steatohepatitis (NASH).
Read More
Multitask Learning Model Outperforms Traditional Machine Learning Models in RCTs, Developers Say
September 16th 2022The proposed multitask learning (MTL) model was developed using data from wearable devices worn by individuals in a randomized controlled trial (RCT) to predict outcomes of a depression treatment.
Read More
AHCL Insulin Delivery Linked to Better QOL, Metabolic Control in Children With T1D
September 15th 2022Children and adolescents with type 1 diabetes (T1D) saw improved quality of life (QOL) and metabolic control when using an advanced hybrid closed-loop (AHCL) insulin delivery method vs conventional therapy.
Read More
Digital Medication Monitor Linked to Better HRQOL, Lower Costs for Tuberculosis
September 15th 2022Patients with tuberculosis who used a digital medication reminder monitor had better health-related quality of life (HRQOL) and lower catastrophic costs compared with patients who used a standard therapy.
Read More
David E. Koren, PharmD, MPH, BCPS, AAHIVP, FIDSA, infectious disease clinical pharmacist at Temple University Hospital, provides an update on current preventive efforts to address the monkeypox public health emergency in the United States and what steps are needed to protect at-risk populations.
Read More
Practices Have to Grapple With the Logistics of Insurers’ Preferred Biosimilars: Dr Lalan Wilfong
September 11th 2022While commercial payers have been engaged with the shift to biosimilars, they all have their own preferred biosimilar, which makes it challenging for practices, explained Lalan Wilfong, MD, vice president of payer relations & practice transformation at The US Oncology Network.
Read More
Subcutaneous Insulin Linked to Reduced Hospital Costs, LOS in Children With Mild DKA
September 10th 2022Treating children with mild diabetic ketoacidosis (DKA) using subcutaneous (SC) insulin aspart was linked to lower hospital costs and better efficacy of DKA management, compared with using intravenous (IV) insulin.
Read More
Dr David Koren on At-Risk Populations, Educational Efforts in Monkeypox
September 9th 2022David E. Koren, PharmD, MPH, BCPS, AAHIVP, FIDSA, infectious disease clinical pharmacist at Temple University Hospital, discussed the risk posed by monkeypox among immunocompromised individuals and men who have sex with men, as well as the need for educational efforts to address misconceptions tied to the disease.
Read More
Rifaximin Plus Lactulose Linked to Greater Effectiveness, Decreased Mortality in HE
September 9th 2022Compared with the use of lactulose alone, rifaximin plus lactulose can provide additional benefits in terms of increased effectiveness rate and decreased mortality in patients with hepatic encephalopathy (HE).
Read More
Burden of Cardiometabolic Risk Factors Differs Between Women, Men With T1D
September 8th 2022Women with type 1 diabetes (T1D) had a better cardiometabolic risk factor profile but did not have a significantly lower cardiovascular disease (CVD) event burden compared with their male counterparts.
Read More
Survey Reveals Injectable HIV PrEP Preferences of Young Men Who Have Sex With Men
September 7th 2022Young men who have sex with men (YMSM) said the treatment’s efficacy was the most important feature injectable HIV pre-exposure prophylaxis (PrEP), over side effects, cost, protection duration, and delivery method.
Read More
Gamified Therapy PDT Yields High Support From Children With Neurodevelopmental Disabilities
September 3rd 2022A digital pet app used as a prescription digital therapeutic (PDT) to encourage children to complete prescribed therapies received high engagement and function scores from children living with neurodevelopmental disabilities.
Read More
Dr David Koren Discusses Response to the Monkeypox Public Health Emergency
September 2nd 2022David E. Koren, PharmD, MPH, BCPS, AAHIVP, FIDSA, infectious disease clinical pharmacist at Temple University Hospital, speaks on gaps in monkeypox vaccine availability and access and steps to improve response to the public health emergency.
Read More